Casey Woodring
Stock Analyst at J.P. Morgan
(1.81)
# 3,191
Out of 4,407 analysts
160
Total ratings
48%
Success rate
0.2%
Average return
Main Sectors:
Stocks Rated by Casey Woodring
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ILMN Illumina | Upgraded: Buy | $125 → $185 | $160.97 | +14.93% | 5 | Jun 10, 2026 | |
| BRKR Bruker | Maintained: Buy | $55 → $65 | $54.23 | +19.86% | 3 | Jun 8, 2026 | |
| TEM Tempus AI | Maintained: Hold | $60 → $50 | $47.82 | +4.56% | 4 | Jun 1, 2026 | |
| ICLR ICON Public Limited Company | Maintained: Hold | $120 → $130 | $146.18 | -11.07% | 17 | May 29, 2026 | |
| A Agilent Technologies | Maintained: Buy | $180 | $129.84 | +38.63% | 4 | May 27, 2026 | |
| TXG 10x Genomics | Maintained: Hold | $17 → $20 | $28.84 | -30.65% | 3 | May 12, 2026 | |
| ALMR Alamar Biosciences | Initiated Coverage: Buy | $30 | $22.00 | +36.36% | 1 | May 12, 2026 | |
| DHR Danaher | Reiterated: Buy | $245 | $180.10 | +36.04% | 7 | May 11, 2026 | |
| MTD Mettler-Toledo International | Rated: Hold | $1,413 → $1,200 | $1,131.49 | +6.05% | 4 | May 11, 2026 | |
| NTRA Natera | Reiterated: Buy | $260 → $265 | $212.07 | +24.96% | 4 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $130 → $135 | $131.62 | +2.57% | 4 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 → $30 | $17.97 | +66.94% | 4 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $15 → $11 | $14.18 | -22.40% | 18 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 → $125 | $101.12 | +23.62% | 6 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $96 → $90 | $99.66 | -9.69% | 3 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $180 → $165 | $130.59 | +26.35% | 3 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $330 → $345 | $355.53 | -2.96% | 4 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 → $8 | $9.39 | -14.80% | 2 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 → $45 | $37.06 | +21.42% | 18 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $710 → $600 | $469.34 | +27.84% | 5 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $190 → $160 | $187.51 | -14.67% | 21 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 → $16 | $16.19 | -1.17% | 14 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $255 | $181.46 | +40.53% | 1 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 → $5 | $4.18 | n/a | 5 | Aug 9, 2024 |
Illumina
Jun 10, 2026
Upgraded: Buy
Price Target: $125 → $185
Current: $160.97
Upside: +14.93%
Bruker
Jun 8, 2026
Maintained: Buy
Price Target: $55 → $65
Current: $54.23
Upside: +19.86%
Tempus AI
Jun 1, 2026
Maintained: Hold
Price Target: $60 → $50
Current: $47.82
Upside: +4.56%
ICON Public Limited Company
May 29, 2026
Maintained: Hold
Price Target: $120 → $130
Current: $146.18
Upside: -11.07%
Agilent Technologies
May 27, 2026
Maintained: Buy
Price Target: $180
Current: $129.84
Upside: +38.63%
10x Genomics
May 12, 2026
Maintained: Hold
Price Target: $17 → $20
Current: $28.84
Upside: -30.65%
Alamar Biosciences
May 12, 2026
Initiated Coverage: Buy
Price Target: $30
Current: $22.00
Upside: +36.36%
Danaher
May 11, 2026
Reiterated: Buy
Price Target: $245
Current: $180.10
Upside: +36.04%
Mettler-Toledo International
May 11, 2026
Rated: Hold
Price Target: $1,413 → $1,200
Current: $1,131.49
Upside: +6.05%
Natera
May 8, 2026
Reiterated: Buy
Price Target: $260 → $265
Current: $212.07
Upside: +24.96%
May 8, 2026
Rated: Buy
Price Target: $130 → $135
Current: $131.62
Upside: +2.57%
May 8, 2026
Maintained: Buy
Price Target: $35 → $30
Current: $17.97
Upside: +66.94%
May 7, 2026
Maintained: Sell
Price Target: $15 → $11
Current: $14.18
Upside: -22.40%
May 7, 2026
Reiterated: Buy
Price Target: $120 → $125
Current: $101.12
Upside: +23.62%
May 6, 2026
Maintained: Hold
Price Target: $96 → $90
Current: $99.66
Upside: -9.69%
May 6, 2026
Maintained: Buy
Price Target: $180 → $165
Current: $130.59
Upside: +26.35%
May 6, 2026
Rated: Hold
Price Target: $330 → $345
Current: $355.53
Upside: -2.96%
Apr 30, 2026
Maintained: Hold
Price Target: $12 → $8
Current: $9.39
Upside: -14.80%
Apr 29, 2026
Maintained: Buy
Price Target: $60 → $45
Current: $37.06
Upside: +21.42%
Apr 24, 2026
Maintained: Buy
Price Target: $710 → $600
Current: $469.34
Upside: +27.84%
Apr 13, 2026
Rated: Hold
Price Target: $190 → $160
Current: $187.51
Upside: -14.67%
Nov 5, 2025
Maintained: Hold
Price Target: $14 → $16
Current: $16.19
Upside: -1.17%
Oct 29, 2025
Reiterated: Buy
Price Target: $255
Current: $181.46
Upside: +40.53%
Aug 9, 2024
Maintained: Hold
Price Target: $6 → $5
Current: $4.18
Upside: n/a